Buscar
Mostrando ítems 1-10 de 408
Nível sérico de infliximabe no tratamento de crianças e adolescentes com doença de Crohn e colite ulcerativa
(Universidade Federal de São Paulo (UNIFESP), 2019-04-01)
Objective: The objective of the study was to compare the Quantum Blue® Infliximab rapid test to ELISA RIDASCREEN® IFX Monitoring test in inflammatory bowel disease pediatric patients and the validation of Quantum Blue® ...
Efectividad para la mejoría clínica del etanercept comparado con infliximab en pacientes con artritis reumatoidea
(Universidad Privada Antenor OrregoPE, 2024)
Objetivos: El objetivo de este estudio es evaluar la efectividad del etanercept
comparado con infliximab en pacientes con artritis reumatoidea.
Material y métodos: Se realizó un estudio observacional de tipo cohorte ...
Efficacy of infliximab in patients with moderate and severe psoriasis treated with infliximab (Remicade®) Eficacia y seguimiento en el largo plazo de pacientes con psoriasis búlgara moderada a severa en tratamiento con infliximab (Remicade®)
(2006)
Background: Psoriasis has a moderate or severe course in 25% of patients, requiring systemic therapy that is not always successful. Infliximab is a human-murine monoclonal anti tumor necrosis alpha (TNF- a) antibody. This ...
Infliximab-induced psoriasis during therapy for Crohn's disease
(Elsevier B.V., 2012-06-01)
Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, ...
Infliximab-induced psoriasis during therapy for Crohn's disease
(Elsevier B.V., 2012-06-01)
Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, ...
Protective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel disease
(SPRINGER, 2008)
Indomethacin administration in animals increases permeability of the small intestine, leading to inflammation that mimics Crohn`s disease. Nonsteroidal anti-inflammatory drugs increase the permeability of the intestinal ...
Infliximabe no tratamento inicial da retocolite ulcerativa moderada e grave. Terapia top down: Relato preliminar
(2008-12-01)
The first option for the treatment of UC is both: salicylates or corticoids. Recently, in late November of 2006, the Brazilian Ministry of Health has approved infliximab (Remicade c, Mantecorp, Brazil) to treat ulcerative ...
Infliximabe no tratamento inicial da retocolite ulcerativa moderada e grave. Terapia top down: Relato preliminar
(2008-12-01)
The first option for the treatment of UC is both: salicylates or corticoids. Recently, in late November of 2006, the Brazilian Ministry of Health has approved infliximab (Remicade c, Mantecorp, Brazil) to treat ulcerative ...
Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
(Baishideng Publishing Group Inc, 2021-05-06)
BACKGROUND Acute severe ulcerative colitis (ASUC) is a complication of ulcerative colitis associated with high levels of circulating tumor necrosis factor alpha, due to the intense inflammation and faster stool clearance ...
Effectiveness of infliximab in patients with Behçet syndrome and severe uveoretinitis. Report of five cases Eficacia del infliximab en pacientes con síndrome de Behçet portadores de úveo-retinitis grave
(2006)
The efficacy and safety of repeated administration of infliximab was evaluated in five patients (two men, three women) with Behçet syndrome accompanied by severe uveoretinitis. Ocular and extra ocular inflammation was ...